Results 161 to 170 of about 14,752 (202)

FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. [PDF]

Antibodies (Basel)
Sandhu M, Murakhovskaya I.
europepmc   +1 more source

Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics. [PDF]

Clin Pharmacokinet
Ternant D, Le Tilly O, Cartron G, Desvignes C, Bensalem A, Mulleman D, Bejan-Angoulvant T, Gouilleux-Gruart V, Paintaud G.   +8 more
europepmc   +1 more source

High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR [PDF]

, 2001
Robert L. Shields, Angela K. Namenuk, Kyu Hong, Y. Gloria Meng, Julie Rae, John B. Briggs, Dong Xie, Jadine Lai, Andrew Stadlen, Betty Li, Judith A. Fox, Leonard G. Presta   +11 more
openalex   +1 more source

Passive Immunity Establishment Through Colostral IgG Absorption in Neonatal Ruminants: Foundation for Efficient Ruminant Production. [PDF]

Animals (Basel)
Yang C, Du M, Ahmad AA, Cheng Y, Gebeyew K.   +4 more
europepmc   +1 more source

Efgartigimod for treating Guillain-Barré syndrome with poor response to intravenous immunoglobulin: a case report. [PDF]

BMC Neurol
Hu BQ, Wu SX, Tong QW, Ye H, Jin PP.
europepmc   +1 more source

A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes

Felix Stader, Cong Liu, Abdallah Derbalah, Hiroshi Momiji, Xian Pan, Iain Gardner, Masoud Jamei, Armin Sepp   +7 more
openalex   +1 more source

Single-cell atlas reveals heterogeneous response to FcRn blockade in anti-AChR antibody-positive generalised myasthenia gravis. [PDF]

Clin Transl Med
Li HN, Liu J, Huang XY, Zhu L, Liu Z, Yang CS, Zhang B, Huang S, Shi FD, Cai Z, Zhang C.   +10 more
europepmc   +1 more source

Influence of the antibody variable domain on FcRn-dependent pharmacokinetics

, 2014
Angela Schoch
openalex   +2 more sources

FcRn inhibitors for myasthenia gravis. [PDF]

Cochrane Database Syst Rev
White LM, Clay FJ, Forbes AM, Keh RYS, Lilleker JB, Spillane J, Storms K, Dodd KC, Sussman J.   +8 more
europepmc   +1 more source

Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia Gravis. [PDF]

CNS Neurosci Ther
Wang Y, Zhu W, Liu Q, Wen X, Xie N, Liu H, Geng Z, Jiang Y, Di L, Wang M, Lu Y, Duo J, Huang Y, Qian Y, Liu Q, Lv C, Da Y.   +16 more
europepmc   +1 more source